FDA Import Refusal AEK-7422072-2/10002/1 — Cipla Pvt Ltd
The FDA refused shipment AEK-7422072-2/10002/1 from Cipla Pvt Ltd (India) on Sep 11, 2025. The refused product falls under Drugs and Biologics — MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 11, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62FCY53 MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 75